Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 22, 2012, Pages 8523-8527

  Kim, Yun Gon ^a   Lone, Anna Mari ^b   Nolte, Whitney M ^b   Saghatelian, Alan ^b  

^a Soongsil University   (South Korea)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; INSULINASE; PEPTIDASE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME SUBSTRATE; FEMALE; IN VIVO STUDY; MALE; MIGRAINE; MOUSE; NONHUMAN; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CALCITONIN GENE-RELATED PEPTIDE; CHROMATOGRAPHY, LIQUID; FEMALE; INSULYSIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPINAL CORD; SUBSTRATE SPECIFICITY; TANDEM MASS SPECTROMETRY;

MUS;

EID: 84861851477     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1203195109     Document Type: Article

References (48)

1. Coll AP, Farooqi IS, O'Rahilly S (2007) The hormonal control of food intake. Cell 129:251-262. (Pubitemid 46574977)
2. Hökfelt T, Bartfai T, Bloom F (2003) Neuropeptides: Opportunities for drug discovery. Lancet Neurol 2:463-472. (Pubitemid 36876103)
3. De Felipe C, et al. (1998) Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392:394-397. (Pubitemid 28168736)
4. Patchett AA, et al. (1980) A new class of angiotensin-converting enzyme inhibitors. Nature 288:280-283. (Pubitemid 11165879)
5. Woods SC, Seeley RJ, Porte D, Jr., Schwartz MW (1998) Signals that regulate food intake and energy homeostasis. Science 280:1378-1383. (Pubitemid 28264819)
6. Ueno H, Yamaguchi H, Kangawa K, Nakazato M (2005) Ghrelin: A gastric peptide that regulates food intake and energy homeostasis. Regul Pept 126:11-19. (Pubitemid 40037738)
7. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806. (Pubitemid 34000783)
8. Thornberry NA, Weber AE (2007) Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Curr Top Med Chem 7:557-568. (Pubitemid 46488280)
9. Che FY, et al. (2001) Identification of peptides from brain and pituitary of Cpe(fat)/Cpe(fat) mice. Proc Natl Acad Sci USA 98:9971-9976.
10. Scamuffa N, Calvo F, Chrétien M, Seidah NG, Khatib AM (2006) Proprotein convertases: Lessons from knockouts. FASEB J 20:1954-1963. (Pubitemid 44953895)
11. Zhou A, Webb G, Zhu X, Steiner DF (1999) Proteolytic processing in the secretory pathway. J Biol Chem 274:20745-20748.
12. Gradman AH, et al. (2005) Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation 111:1012-1018. (Pubitemid 40354519)
13. Marguet D, et al. (2000) Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci USA 97:6874-6879. (Pubitemid 30412807)
14. Lankas GR, et al. (2005) Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: Potential importance of selectivity over dipeptidyl peptidases 8 and 9. Diabetes 54:2988-2994. (Pubitemid 41401097)
15. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240-244. (Pubitemid 12089405)
16. Mason RT, et al. (1984) Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells. Nature 308:653-655. (Pubitemid 14129579)
17. Brain S, Williams T, Tippins J, Morris H (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313:54-56. (Pubitemid 15192304)
18. Tsujikawa K, et al. (2007) Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci USA 104:16702-16707. (Pubitemid 350211080)
19. Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J (2000) Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain 86:133-138. (Pubitemid 30211712)
20. Tepper SJ, Stillman MJ (2008) Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine. Headache 48:1259-1268.
21. Olesen J, et al.; BIBN 4096 BS Clinical Proof of Concept Study Group (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104-1110. (Pubitemid 38298990)
22. Yang D, et al. (2010) Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 12:130-141.
23. Katayama M, et al. (1991) Catabolism of calcitonin gene-related peptide and substance P by neutral endopeptidase. Peptides 12:563-567.
24. Le Grevès P, Andersson K, Silberring J (1997) Isolation and identification of CGRP Cterminal fragments in the rat spinal cord. Neuropeptides 31:19-23. (Pubitemid 27112609)
25. Le Grevès P, Nyberg F, Hökfelt T, Terenius L (1989) Calcitonin gene-related peptide is metabolized by an endopeptidase hydrolyzing substance P. Regul Pept 25:277-286. (Pubitemid 19182278)
26. Tam EK, Caughey GH (1990) Degradation of airway neuropeptides by human lung tryptase. Am J Respir Cell Mol Biol 3:27-32.
27. Clynen E, Baggerman G, Husson S, Landuyt B, Schoofs L (2008) Peptidomics in drug research. Expert Opinion on Drug Discovery 3:425-440. (Pubitemid 351618769)
28. Jankowski V, et al. (2007) Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol 27:297-302. (Pubitemid 46143043)
29. Tinoco AD, Tagore DM, Saghatelian A (2010) Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform. J Am Chem Soc 132:3819-3830.
30. Rawlings ND, Barrett AJ, Bateman A (2010) MEROPS: The peptidase database. Nucleic Acids Res 38(Database issue):D227-D233.
31. Duckworth WC, Heinemann MA, Kitabchi AE (1972) Purification of insulin-specific protease by affinity chromatography. Proc Natl Acad Sci USA 69:3698-3702.
32. Ray K, Hines CS, Rodgers DW (2002) Mapping sequence differences between thimet oligopeptidase and neurolysin implicates key residues in substrate recognition. Protein Sci 11:2237-2246. (Pubitemid 34919627)
33. Oliveira V, et al. (2001) Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin. Biochemistry 40:4417-4425. (Pubitemid 32319587)
34. Farris W, et al. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100:4162-4167. (Pubitemid 36418174)
35. Shen Y, Joachimiak A, Rosner MR, Tang WJ (2006) Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443:870-874. (Pubitemid 44622699)
36. Miller BC, et al. (2003) Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100:6221-6226. (Pubitemid 36576957)
37. Yamaguchi H, et al. (2007) Peptidomic identification and biological validation of neuroendocrine regulatory peptide-1 and -2. J Biol Chem 282:26354-26360. (Pubitemid 47443772)
38. Glebov K, Walter J (2012) Statins in Unconventional Secretion of Insulin-Degrading Enzyme and Degradation of the Amyloid-β Peptide. Neurodegener Dis 10:309-312.
39. Tamboli IY, et al. (2010) Statins promote the degradation of extracellular amyloid beta-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion. J Biol Chem 285:37405-37414.
40. Keshishian H, et al. (2009) Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 8:2339-2349.
41. Sladek R, et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885.
42. Zeggini E, et al.; Wellcome Trust Case Control Consortium (WTCCC) (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336-1341. (Pubitemid 46871654)
43. Bertram L, et al. (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290:2302-2303. (Pubitemid 32041570)
44. Farris W, et al. (2004) Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164:1425-1434. (Pubitemid 38387808)
45. Blomqvist ME, et al. (2005) Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging 26:795-802. (Pubitemid 40249481)
46. Cabrol C, et al. (2009) Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening. PLoS ONE 4:e5274.
47. Leissring MA, et al. (2010) Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE 5:e10504.
48. Stengel A, et al. (2009) The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 150:5113-5118.